GWSG
LEGN icon

GPS Wealth Strategies Group’s Legend Biotech LEGN Stock Holding History

GPS Wealth Strategies Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$978 Hold
45
– – ﹤0.01% 554
2025
Q3 		$1.47K Hold
45
– – ﹤0.01% 1443
2025
Q2 		$1.6K Hold
45
– – ﹤0.01% 1382
2025
Q1 		$1.53K Hold
45
– – ﹤0.01% 1337
2024
Q4 		$1.46K Hold
45
– – ﹤0.01% 1268
2024
Q3 		$2.19K Hold
45
– – ﹤0.01% 1223
2024
Q2 		$1.99K Hold
45
– – ﹤0.01% 1208
2024
Q1 		$2.52K Hold
45
– – ﹤0.01% 1107
2023
Q4 		$2.71K Buy
+45
New +$2.85K ﹤0.01% 1082

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

GPS Wealth Strategies Group's LEGN Position: Q4 2025 in Review

GPS Wealth Strategies Group held its Legend Biotech (LEGN) position steady in Q4 2025 at 45 shares worth $978. The position accounts for ﹤0.01% of the portfolio, ranked #554.

GPS Wealth Strategies Group first reported a position in LEGN in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.71K in Q4 2023. 200 funds tracked by Wall St. Rank hold LEGN as of Q4 2025.

  • GPS Wealth Strategies Group held 45 shares of Legend Biotech worth $978 as of Q4 2025.
  • GPS Wealth Strategies Group left its Legend Biotech share count unchanged in Q4 2025.
  • Legend Biotech made up ﹤0.01% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #554 holding.
  • GPS Wealth Strategies Group first reported a position in Legend Biotech in Q4 2023 and has held it in 9 quarters since.
  • GPS Wealth Strategies Group's Legend Biotech position peaked at $2.71K in Q4 2023.
  • 200 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.